{"id":41372,"date":"2018-05-09T11:00:53","date_gmt":"2018-05-09T02:00:53","guid":{"rendered":"http:\/\/www.veeva.com\/jp\/?p=41372"},"modified":"2018-05-08T17:52:48","modified_gmt":"2018-05-08T08:52:48","slug":"debiopharm-international-sa-strengthens-compliance-and-clinical-trial-oversight-with-veeva-vault-etmf","status":"publish","type":"post","link":"https:\/\/www.veeva.com\/jp\/news\/debiopharm-international-sa-strengthens-compliance-and-clinical-trial-oversight-with-veeva-vault-etmf\/","title":{"rendered":"Debiopharm International SA\u793e\u3001Veeva Vault eTMF\u3067\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u3068\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3051\u308b\u30aa\u30fc\u30d0\u30fc\u30b5\u30a4\u30c8\u3092\u5f37\u5316"},"content":{"rendered":"<p style=\"text-align: right;\">2018\u5e745\u67089\u65e5<\/p>\n<p style=\"text-align: right;\">Veeva Japan\u682a\u5f0f\u4f1a\u793e<\/p>\n<p>&nbsp;<\/p>\n<p>Veeva Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751 \u5d07\u3001\u4ee5\u4e0b Veeva)\u306f\u3001\u30b9\u30a4\u30b9\u306b\u62e0\u70b9\u3092\u7f6e\u304f\u30d0\u30a4\u30aa\u533b\u85ac\u54c1\u4f01\u696d\u3067\u3042\u308bDebiopharm Group&#x2122;\u306e\u30b0\u30eb\u30fc\u30d7\u4f01\u696d\u3001<strong><a href=\"http:\/\/www.debiopharm.com\/\">Debiopharm International SA<\/a><\/strong>\uff08\u4ee5\u4e0bDebiopharm\u793e\uff09\u304c\u3001<strong><a href=\"https:\/\/www.veeva.com\/jp\/products\/vault-etmf\/\">Veeva Vault eTMF<\/a><\/strong>\u3092\u63a1\u7528\u3057\u305f\u3053\u3068\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002Veeva Vault eTMF\u3092\u5229\u7528\u3057\u3001\u5358\u4e00\u306e\u30af\u30e9\u30a6\u30c9\u30d9\u30fc\u30b9\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u4e0a\u3067\u500b\u3005\u306e\u533b\u85ac\u54c1\u958b\u767a\u6a5f\u95a2\uff08CRO\uff09\u3068\u30b3\u30e9\u30dc\u30ec\u30fc\u30b7\u30e7\u30f3\u3059\u308b\u3053\u3068\u306b\u3088\u308a\u3001\u6cbb\u9a13\u30de\u30b9\u30bf\u30fc\u30d5\u30a1\u30a4\u30eb\uff08TMF\uff09\u30d7\u30ed\u30bb\u30b9\u5168\u4f53\u306e\u30aa\u30fc\u30d0\u30fc\u30b5\u30a4\u30c8\u3092\u6539\u5584\u3057\u3001\u3088\u308a\u7dca\u5bc6\u306a\u5354\u696d\u3092\u9032\u3081\u307e\u3059\u3002 (\u672c\u30ea\u30ea\u30fc\u30b9\u306f\u3001Veeva\u7c73\u56fd\u672c\u793e\u304c\u767a\u8868\u3057\u305f\u5831\u9053\u8cc7\u6599\u306e\u6284\u8a33\u3067\u3059)<\/p>\n<p>&nbsp;<\/p>\n<p>Debiopharm\u793e\u306e\u30af\u30ea\u30cb\u30ab\u30eb\u30aa\u30da\u30ec\u30fc\u30b7\u30e7\u30f3\u62c5\u5f53\u30c7\u30a3\u30ec\u30af\u30bf\u30fc\u3067\u3042\u308bChristian A. Aeschlimann\u6c0f\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300cVeeva\u306f\u3001\u5f53\u793e\u306e\u81e8\u5e8a\u8a66\u9a13\u30aa\u30da\u30ec\u30fc\u30b7\u30e7\u30f3\u306e\u5408\u7406\u5316\u3092\u652f\u63f4\u3057\u3066\u3044\u307e\u3059\u3002Veeva Vault eTMF\u306b\u3088\u308a\u3001\u79c1\u305f\u3061\u306f\u5e38\u306b\u6b63\u78ba\u3067\u6700\u65b0\u306eTMF\u3092\u7dad\u6301\u3067\u304d\u3001\u540c\u4e00\u306e\u30b7\u30b9\u30c6\u30e0\u3067\u4f5c\u696d\u3059\u308b\u3053\u3068\u3067\u3001\u5916\u90e8\u306e\u30d1\u30fc\u30c8\u30ca\u30fc\u3068\u306e\u8abf\u6574\u304c\u5bb9\u6613\u306b\u306a\u308a\u307e\u3059\u3002\u300d<\/p>\n<p>Debiopharm\u793e\u306f\u3001\u6cbb\u9a13\u4f9d\u983c\u8005\u3068\u3057\u3066\u3001ICH E6(R2) \u306b\u6e96\u62e0\u3057\u3066\u81e8\u5e8a\u8a66\u9a13\u5168\u4f53\u3092\u901a\u3058\u305f\u30aa\u30fc\u30d0\u30fc\u30b5\u30a4\u30c8\u3092\u7dad\u6301\u3059\u308b\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002\u5916\u90e8\u30d1\u30fc\u30c8\u30ca\u30fc\u306f\u3001\u540c\u793e\u304c\u304b\u3064\u3066\u5229\u7528\u3057\u3066\u3044\u305f\u30aa\u30f3\u30d7\u30ec\u30df\u30b9\u306eeTMF\u306b\u306f\u30a2\u30af\u30bb\u30b9\u3067\u304d\u306a\u304b\u3063\u305f\u305f\u3081\u3001CRO\u306f\u72ec\u81ea\u306e\u30b7\u30b9\u30c6\u30e0\u3092\u5229\u7528\u3057\u3066\u6587\u66f8\u3092\u5b9a\u671f\u7684\u306b\u79fb\u7ba1\u3055\u305b\u3066\u3044\u307e\u3057\u305f\u3002\u3064\u307e\u308a\u3001Debiopharm\u793e\u306f\u3001CRO\u306eTMF\u696d\u52d9\u306b\u5bfe\u3057\u3001\u30ea\u30a2\u30eb\u30bf\u30a4\u30e0\u306e\u5b8c\u5168\u306a\u53ef\u8996\u6027\u3092\u78ba\u4fdd\u3067\u304d\u3066\u3044\u307e\u305b\u3093\u3067\u3057\u305f\u3002<\/p>\n<p>Veeva Vault eTMF\u306f\u3001\u8a66\u9a13\u306e\u30c9\u30ad\u30e5\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u306b\u304a\u3051\u308b\u60c5\u5831\u306e\u4e00\u5143\u7ba1\u7406\u3092\u5b9f\u73fe\u3057\u307e\u3059\u3002\u6cbb\u9a13\u4f9d\u983c\u8005\u3068CRO\u306f\u3001\u8a66\u9a13\u5b9f\u65bd\u306e\u90fd\u5ea6\u3001TMF\u6587\u66f8\u3068\u30d7\u30ed\u30bb\u30b9\u3092\u540c\u4e00\u30b7\u30b9\u30c6\u30e0\u4e0a\u3067\u30ea\u30a2\u30eb\u30bf\u30a4\u30e0\u306b\u7ba1\u7406\u3067\u304d\u307e\u3059\u3002\u3053\u308c\u306b\u3088\u308aDebiopharm\u793e\u306f\u3001\u5e38\u306b\u67fb\u5bdf\u306e\u6e96\u5099\u304c\u6574\u3063\u305f\u72b6\u614b\u3067TMF\u3092\u7dad\u6301\u3067\u304d\u308b\u305f\u3081\u3001\u30d1\u30fc\u30c8\u30ca\u30fc\u306e\u6a19\u6e96\u696d\u52d9\u624b\u9806\u66f8\uff08SOP\uff09\u901a\u308a\u306e\u696d\u52d9\u9042\u884c\u3092\u9075\u5b88\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3057\u305f\u3002<\/p>\n<p>Debiopharm\u793e\u306e\u30af\u30ea\u30cb\u30ab\u30eb\u30aa\u30da\u30ec\u30fc\u30b7\u30e7\u30f3\u30de\u30cd\u30b8\u30e3\u30fc\u3067\u3042\u308bVincent Demeautis\u6c0f\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300c\u5f53\u793e\u306f\u7d99\u7d9a\u7684\u306a\u6539\u5584\u3092\u8ffd\u6c42\u3059\u308b\u4e2d\u3067\u3001\u4f5c\u696d\u3092\u3088\u308a\u52b9\u7387\u7684\u306b\u884c\u3044\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3051\u308b\u54c1\u8cea\u306e\u30c9\u30ad\u30e5\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u3092\u7dad\u6301\u3067\u304d\u308b\u3088\u3046\u306b\u3059\u308b\u305f\u3081\u3001Veeva Vault eTMF\u3092\u63a1\u7528\u3057\u307e\u3057\u305f\u3002\u3053\u306e\u5358\u4e00\u306e\u30b7\u30b9\u30c6\u30e0\u3092TMF\u306e\u3059\u3079\u3066\u306e\u30d7\u30ed\u30bb\u30b9\u3092\u9032\u3081\u308b\u5404CRO\u3068\u5171\u6709\u3059\u308b\u3053\u3068\u306b\u3088\u308a\u3001\u8907\u6570\u306eTMF\u30bd\u30fc\u30b9\u3092\u7ba1\u7406\u3057\u3001\u4e00\u81f4\u3055\u305b\u308b\u5fc5\u8981\u304c\u306a\u304f\u306a\u308b\u3068\u540c\u6642\u306b\u3001\u3088\u308a\u8fc5\u901f\u306a\u5bfe\u5fdc\u304c\u3067\u304d\u308b\u3046\u3048\u3001\u793e\u5185\u5916\u306e\u8a66\u9a13\u30c1\u30fc\u30e0\u30e1\u30f3\u30d0\u30fc\u3068\u306e\u3088\u308a\u7dca\u5bc6\u306a\u9023\u643a\u304c\u53ef\u80fd\u306b\u306a\u308a\u307e\u3059\u3002\u300d<\/p>\n<p>\u66f4\u306bDebiopharm\u793e\u306f\u3001Veeva Vault eTMF\u306e\u30ec\u30dd\u30fc\u30c8\u3068\u30c0\u30c3\u30b7\u30e5\u30dc\u30fc\u30c9\u6a5f\u80fd\u306b\u3088\u308a\u3001TMF\u306e\u5b8c\u4e86\u7387\u3001\u9069\u6642\u6027\u3001\u6b63\u78ba\u6027\u3092\u78ba\u8a8d\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3059\u3002\u3053\u308c\u306b\u3088\u308a\u540c\u793e\u306f\u3001\u30c9\u30ad\u30e5\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u306e\u72b6\u614b\u3068\u54c1\u8cea\u3092\u78ba\u8a8d\u3057\u3001\u3069\u306e\u3088\u3046\u306a\u554f\u984c\u304c\u767a\u751f\u3057\u3066\u3082\u30d7\u30ed\u30a2\u30af\u30c6\u30a3\u30d6\u306b\u89e3\u6c7a\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3059\u3002<\/p>\n<p>Debiopharm\u793e\u3067Veeva Vault eTMF\u306e\u5c0e\u5165\u3092\u63a8\u9032\u3057\u305f\u30b7\u30cb\u30a2\u30af\u30ea\u30cb\u30ab\u30eb\u30c8\u30e9\u30a4\u30a2\u30eb\u30a2\u30bd\u30b7\u30a8\u30fc\u30c8\u3001Sofie Lemmens\u6c0f\u306f\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300cVeeva Vault eTMF\u306f\u3001\u5f53\u793e\u306e\u73fe\u5728\u305d\u3057\u3066\u5c06\u6765\u306e\u30cb\u30fc\u30ba\u306b\u5408\u81f4\u3057\u305f\u3001\u5e02\u5834\u3067\u6700\u3082\u512a\u308c\u305f\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3067\u3057\u305f\u3002\u3053\u306e\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306f\u3001TMF\u306e\u54c1\u8cea\u3068\u30a2\u30af\u30bb\u30b9\u3092\u6539\u5584\u3059\u308b\u305f\u3081\u306e\u3001\u793e\u5185\u306e\u30c1\u30fc\u30e0\u3059\u3079\u3066\u306b\u5bfe\u3059\u308b\u91cd\u8981\u306a\u6295\u8cc7\u3067\u3057\u305f\u3002\u300d<\/p>\n<p>Veeva Vault eTMF\u306e\u5c0e\u5165\u306b\u3088\u308a\u3001Debiopharm\u793e\u306f\u7d71\u5408\u5316\u3055\u308c\u305f\u81e8\u5e8a\u8a66\u9a13\u30e2\u30c7\u30eb\u3078\u306e\u7b2c\u4e00\u6b69\u3092\u8e0f\u307f\u51fa\u3057\u3001\u30a8\u30f3\u30c9\u30c4\u30fc\u30a8\u30f3\u30c9\u306e\u30d7\u30ed\u30bb\u30b9\u3068\u30b7\u30b9\u30c6\u30e0\u306e\u5408\u7406\u5316\u3001\u9023\u643a\u306e\u5f37\u5316\u3001\u305d\u3057\u3066\u81e8\u5e8a\u8a66\u9a13\u5168\u4f53\u306e\u30d1\u30d5\u30a9\u30fc\u30de\u30f3\u30b9\u5411\u4e0a\u3092\u76ee\u6307\u3057\u307e\u3059\u3002\u3053\u308c\u306f\u696d\u754c\u5168\u4f53\u306e\u52d5\u5411\u3092\u53cd\u6620\u3057\u3066\u304a\u308a\u3001<strong><a href=\"https:\/\/www.veeva.com\/jp\/ClinicalSurvey2017\/\">Veeva 2017 Unified Clinical Operations Survey<\/a><\/strong>\u306e\u56de\u7b54\u8005\u306e\u307b\u307c\u5168\u54e1\uff0899%\uff09\u304c\u3001\u81e8\u5e8a\u8a66\u9a13\u30aa\u30da\u30ec\u30fc\u30b7\u30e7\u30f3\u3092\u7d71\u5408\u5316\u3059\u308b\u5fc5\u8981\u304c\u3042\u308b\u3068\u5831\u544a\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>Veeva\u306e\u30e8\u30fc\u30ed\u30c3\u30d1R&amp;D\u30b9\u30c8\u30e9\u30c6\u30b8\u30fc\u62c5\u5f53\u30f4\u30a1\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u3067\u3042\u308bRik Van Mol\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002\u300c\u6cbb\u9a13\u4f9d\u983c\u8005\u306f\u3001\u30b7\u30b9\u30c6\u30e0\u3068\u30d7\u30ed\u30bb\u30b9\u306e\u7d71\u5408\u5316\u3092\u9032\u3081\u308b\u3053\u3068\u306b\u3088\u308a\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u54c1\u8cea\u3092\u5411\u4e0a\u3055\u305b\u3001\u8a66\u9a13\u5b9f\u65bd\u3092\u52b9\u7387\u5316\u3059\u308b\u3068\u5171\u306b\u3001\u5897\u5927\u3059\u308b\u81e8\u5e8a\u8a66\u9a13\u6570\u3068\u307e\u3059\u307e\u3059\u8907\u96d1\u5316\u3057\u3066\u3044\u308b\u81e8\u5e8a\u8a66\u9a13\u30e9\u30a4\u30d5\u30b5\u30a4\u30af\u30eb\u5168\u4f53\u3092\u7ba1\u7406\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3059\u3002Debiopharm\u793e\u306f\u3001Veeva Vault eTMF\u306b\u3088\u308a\u81e8\u5e8a\u8a66\u9a13\u306e\u53ef\u8996\u6027\u3068\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u3092\u5411\u4e0a\u3055\u305b\u3001\u7d71\u5408\u5316\u3055\u308c\u305f\u81e8\u5e8a\u8a66\u9a13\u30aa\u30da\u30ec\u30fc\u30b7\u30e7\u30f3\u3078\u3068\u79fb\u884c\u3067\u304d\u307e\u3059\u3002\u300d<\/p>\n<p>Veeva Vault eTMF\u306f<strong><a href=\"https:\/\/www.veeva.com\/jp\/products\/vault-clinical\/\">Veeva Vault Clinical Suite<\/a><\/strong>\u306e\u4e00\u90e8\u3067\u3059\u3002\u3053\u306e\u30b9\u30a4\u30fc\u30c8\u306f\u3001eTMF\u3001EDC\u3001CTMS\u3001\u304a\u3088\u3073study start-up\u3092\u7d44\u307f\u5408\u308f\u305b\u305f\u696d\u754c\u521d\u306e\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u30b9\u30a4\u30fc\u30c8\u3067\u3001\u81e8\u5e8a\u8a66\u9a13\u30c7\u30fc\u30bf\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u3068\u81e8\u5e8a\u8a66\u9a13\u30aa\u30da\u30ec\u30fc\u30b7\u30e7\u30f3\u3092\u7d71\u5408\u5316\u3057\u307e\u3059\u3002Veeva Vault Clinical Suite\u306e\u5229\u7528\u306b\u3088\u308a\u3001\u5404\u81e8\u5e8a\u8a66\u9a13\u30aa\u30da\u30ec\u30fc\u30b7\u30e7\u30f3\u306b\u308f\u305f\u308b\u30b7\u30b9\u30c6\u30e0\u306e\u30b5\u30a4\u30ed\u5316\u3092\u7d44\u7e54\u304c\u3044\u304b\u306b\u3057\u3066\u53d6\u308a\u9664\u3044\u3066\u3044\u308b\u306e\u304b\u3001\u662f\u975e<strong><a href=\"https:\/\/www.veeva.com\/jp\/products\/vault-clinical\/\">veeva.com\/jp\/Clinical<\/a><\/strong>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n<p>&nbsp;<\/p>\n<p><strong>\u3010Veeva Systems\u793e\u306b\u3064\u3044\u3066\u3011<br \/>\n<\/strong>Veeva Systems\u793e\u306f\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u3084\u305d\u306e\u4ed6\u306e\u898f\u5236\u3092\u53d7\u3051\u308b\u88fd\u9020\u696d\u8005\u5411\u3051\u306b\u3001\u30af\u30e9\u30a6\u30c9\u30d9\u30fc\u30b9\u306e\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3092\u63d0\u4f9b\u3059\u308b\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30ab\u30f3\u30d1\u30cb\u30fc\u3067\u3059\u3002\u4e16\u754c\u6700\u5927\u898f\u6a21\u306e\u88fd\u85ac\u4f1a\u793e\u304b\u3089\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u5206\u91ce\u306e\u65b0\u8208\u4f01\u696d\u307e\u3067600\u793e\u3092\u8d85\u3048\u308b\u9867\u5ba2\u3092\u64c1\u3057\u3001\u6280\u8853\u9769\u65b0\u3078\u306e\u53d6\u308a\u7d44\u307f\u3084\u5353\u8d8a\u3057\u305f\u88fd\u54c1\u529b\u306b\u3088\u3063\u3066\u3001\u304a\u5ba2\u69d8\u306e\u6210\u529f\u3092\u30b5\u30dd\u30fc\u30c8\u3057\u3066\u3044\u307e\u3059\u3002Veeva\u306f\u3001\u30b5\u30f3\u30d5\u30e9\u30f3\u30b7\u30b9\u30b3\u306e\u30d9\u30a4\u30a8\u30ea\u30a2\u306b\u672c\u793e\u3092\u7f6e\u304d\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3001\u30a2\u30b8\u30a2\u3001\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\u306b\u62e0\u70b9\u3092\u5c55\u958b\u3057\u3066\u3044\u307e\u3059\u3002\u8a73\u3057\u304f\u306f\u3001<strong><a href=\"https:\/\/veeva.com\/jp\/\" target=\"_blank\" rel=\"noopener noreferrer\">\u516c\u5f0f\u30b5\u30a4\u30c8<\/a><\/strong>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n<p><strong>\u3010Forward-looking Statements\u3011<\/strong><br \/>\nThis release contains forward-looking statements, including the market demand for and acceptance of Veeva\u2019s products and services, the results from use of Veeva\u2019s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon Veeva\u2019s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva\u2019s financial results are included under the captions, \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations,\u201d in the company\u2019s filing on Form 10-Q for the period ended January 31, 2018. This is available on the company\u2019s website at <a href=\"https:\/\/www.veeva.com\/\">www.veeva.com<\/a> under the Investors section and on the SEC\u2019s website at <a href=\"http:\/\/www.sec.gov\/\">www.sec.gov<\/a>. Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>2018\u5e745\u67089\u65e5 Veeva Japan\u682a\u5f0f\u4f1a\u793e &nbsp; Veeva Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751 &hellip;<\/p>\n","protected":false},"author":131,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[322],"tags":[],"class_list":["post-41372","post","type-post","status-publish","format-standard","hentry","category-press-release","blog-product-veeva-rd"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO Pro 5.0.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"Debiopharm\u793e\u30b7\u30cb\u30a2\u30af\u30ea\u30cb\u30ab\u30eb\u30c8\u30e9\u30a4\u30a2\u30eb\u30a2\u30bd\u30b7\u30a8\u30fc\u30c8\u3001Sofie Lemmens\u6c0f\u30b3\u30e1\u30f3\u30c8\uff08\u629c\u7c8b\uff09\u300cVeeva Vault eTMF\u306f\u3001\u5f53\u793e\u306e\u73fe\u5728\u305d\u3057\u3066\u5c06\u6765\u306e\u30cb\u30fc\u30ba\u306b\u5408\u81f4\u3057\u305f\u3001\u5e02\u5834\u3067\u6700\u3082\u512a\u308c\u305f\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3067\u3057\u305f\u3002\u300dDebiopharm\u793e\u306fVeeva Vault eTMF\u3092\u5229\u7528\u3057\u3001TMF\u30d7\u30ed\u30bb\u30b9\u5168\u4f53\u306e\u30aa\u30fc\u30d0\u30fc\u30b5\u30a4\u30c8\u3092\u6539\u5584\u3057\u3066\u3001\u3088\u308a\u7dca\u5bc6\u306a\u5354\u696d\u3092\u63a8\u9032\u3002\" \/>\n\t<meta name=\"robots\" content=\"max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n\t<meta name=\"author\" content=\"taeko.tajima@veeva.com\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.veeva.com\/jp\/news\/debiopharm-international-sa-strengthens-compliance-and-clinical-trial-oversight-with-veeva-vault-etmf\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO Pro (AIOSEO) 5.0.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"ja_JP\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Veeva Japan\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Debiopharm International SA\u793e\u3001Veeva Vault eTMF\u3067\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u3068\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3051\u308b\u30aa\u30fc\u30d0\u30fc\u30b5\u30a4\u30c8\u3092\u5f37\u5316 | Veeva Japan\" \/>\n\t\t<meta property=\"og:description\" content=\"Debiopharm\u793e\u30b7\u30cb\u30a2\u30af\u30ea\u30cb\u30ab\u30eb\u30c8\u30e9\u30a4\u30a2\u30eb\u30a2\u30bd\u30b7\u30a8\u30fc\u30c8\u3001Sofie Lemmens\u6c0f\u30b3\u30e1\u30f3\u30c8\uff08\u629c\u7c8b\uff09\u300cVeeva Vault eTMF\u306f\u3001\u5f53\u793e\u306e\u73fe\u5728\u305d\u3057\u3066\u5c06\u6765\u306e\u30cb\u30fc\u30ba\u306b\u5408\u81f4\u3057\u305f\u3001\u5e02\u5834\u3067\u6700\u3082\u512a\u308c\u305f\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3067\u3057\u305f\u3002\u300dDebiopharm\u793e\u306fVeeva Vault eTMF\u3092\u5229\u7528\u3057\u3001TMF\u30d7\u30ed\u30bb\u30b9\u5168\u4f53\u306e\u30aa\u30fc\u30d0\u30fc\u30b5\u30a4\u30c8\u3092\u6539\u5584\u3057\u3066\u3001\u3088\u308a\u7dca\u5bc6\u306a\u5354\u696d\u3092\u63a8\u9032\u3002\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.veeva.com\/jp\/news\/debiopharm-international-sa-strengthens-compliance-and-clinical-trial-oversight-with-veeva-vault-etmf\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2018-05-09T02:00:53+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2018-05-08T08:52:48+00:00\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/news\\\/debiopharm-international-sa-strengthens-compliance-and-clinical-trial-oversight-with-veeva-vault-etmf\\\/#article\",\"name\":\"Debiopharm International SA\\u793e\\u3001Veeva Vault eTMF\\u3067\\u30b3\\u30f3\\u30d7\\u30e9\\u30a4\\u30a2\\u30f3\\u30b9\\u3068\\u81e8\\u5e8a\\u8a66\\u9a13\\u306b\\u304a\\u3051\\u308b\\u30aa\\u30fc\\u30d0\\u30fc\\u30b5\\u30a4\\u30c8\\u3092\\u5f37\\u5316 | Veeva Japan\",\"headline\":\"Debiopharm International SA\\u793e\\u3001Veeva Vault eTMF\\u3067\\u30b3\\u30f3\\u30d7\\u30e9\\u30a4\\u30a2\\u30f3\\u30b9\\u3068\\u81e8\\u5e8a\\u8a66\\u9a13\\u306b\\u304a\\u3051\\u308b\\u30aa\\u30fc\\u30d0\\u30fc\\u30b5\\u30a4\\u30c8\\u3092\\u5f37\\u5316\",\"author\":{\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/author\\\/taeko-tajimaveeva-com\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/#organization\"},\"datePublished\":\"2018-05-09T11:00:53+09:00\",\"dateModified\":\"2018-05-08T17:52:48+09:00\",\"inLanguage\":\"ja\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/news\\\/debiopharm-international-sa-strengthens-compliance-and-clinical-trial-oversight-with-veeva-vault-etmf\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/news\\\/debiopharm-international-sa-strengthens-compliance-and-clinical-trial-oversight-with-veeva-vault-etmf\\\/#webpage\"},\"articleSection\":\"\\u30d7\\u30ec\\u30b9\\u30ea\\u30ea\\u30fc\\u30b9, Veeva R&amp;D\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/news\\\/debiopharm-international-sa-strengthens-compliance-and-clinical-trial-oversight-with-veeva-vault-etmf\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp#listItem\",\"position\":1,\"name\":\"\\u30db\\u30fc\\u30e0\",\"item\":\"https:\\\/\\\/www.veeva.com\\\/jp\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/category\\\/press-release\\\/#listItem\",\"name\":\"\\u30d7\\u30ec\\u30b9\\u30ea\\u30ea\\u30fc\\u30b9\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/category\\\/press-release\\\/#listItem\",\"position\":2,\"name\":\"\\u30d7\\u30ec\\u30b9\\u30ea\\u30ea\\u30fc\\u30b9\",\"item\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/category\\\/press-release\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/news\\\/debiopharm-international-sa-strengthens-compliance-and-clinical-trial-oversight-with-veeva-vault-etmf\\\/#listItem\",\"name\":\"Debiopharm International SA\\u793e\\u3001Veeva Vault eTMF\\u3067\\u30b3\\u30f3\\u30d7\\u30e9\\u30a4\\u30a2\\u30f3\\u30b9\\u3068\\u81e8\\u5e8a\\u8a66\\u9a13\\u306b\\u304a\\u3051\\u308b\\u30aa\\u30fc\\u30d0\\u30fc\\u30b5\\u30a4\\u30c8\\u3092\\u5f37\\u5316\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp#listItem\",\"name\":\"\\u30db\\u30fc\\u30e0\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/news\\\/debiopharm-international-sa-strengthens-compliance-and-clinical-trial-oversight-with-veeva-vault-etmf\\\/#listItem\",\"position\":3,\"name\":\"Debiopharm International SA\\u793e\\u3001Veeva Vault eTMF\\u3067\\u30b3\\u30f3\\u30d7\\u30e9\\u30a4\\u30a2\\u30f3\\u30b9\\u3068\\u81e8\\u5e8a\\u8a66\\u9a13\\u306b\\u304a\\u3051\\u308b\\u30aa\\u30fc\\u30d0\\u30fc\\u30b5\\u30a4\\u30c8\\u3092\\u5f37\\u5316\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/category\\\/press-release\\\/#listItem\",\"name\":\"\\u30d7\\u30ec\\u30b9\\u30ea\\u30ea\\u30fc\\u30b9\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/#organization\",\"name\":\"Veeva Systems Japan\",\"description\":\"The Industry Cloud for Life Sciences\",\"url\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/\",\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/veeva-japan\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/author\\\/taeko-tajimaveeva-com\\\/#author\",\"url\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/author\\\/taeko-tajimaveeva-com\\\/\",\"name\":\"taeko.tajima@veeva.com\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/news\\\/debiopharm-international-sa-strengthens-compliance-and-clinical-trial-oversight-with-veeva-vault-etmf\\\/#webpage\",\"url\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/news\\\/debiopharm-international-sa-strengthens-compliance-and-clinical-trial-oversight-with-veeva-vault-etmf\\\/\",\"name\":\"Debiopharm International SA\\u793e\\u3001Veeva Vault eTMF\\u3067\\u30b3\\u30f3\\u30d7\\u30e9\\u30a4\\u30a2\\u30f3\\u30b9\\u3068\\u81e8\\u5e8a\\u8a66\\u9a13\\u306b\\u304a\\u3051\\u308b\\u30aa\\u30fc\\u30d0\\u30fc\\u30b5\\u30a4\\u30c8\\u3092\\u5f37\\u5316 | Veeva Japan\",\"description\":\"Debiopharm\\u793e\\u30b7\\u30cb\\u30a2\\u30af\\u30ea\\u30cb\\u30ab\\u30eb\\u30c8\\u30e9\\u30a4\\u30a2\\u30eb\\u30a2\\u30bd\\u30b7\\u30a8\\u30fc\\u30c8\\u3001Sofie Lemmens\\u6c0f\\u30b3\\u30e1\\u30f3\\u30c8\\uff08\\u629c\\u7c8b\\uff09\\u300cVeeva Vault eTMF\\u306f\\u3001\\u5f53\\u793e\\u306e\\u73fe\\u5728\\u305d\\u3057\\u3066\\u5c06\\u6765\\u306e\\u30cb\\u30fc\\u30ba\\u306b\\u5408\\u81f4\\u3057\\u305f\\u3001\\u5e02\\u5834\\u3067\\u6700\\u3082\\u512a\\u308c\\u305f\\u30bd\\u30ea\\u30e5\\u30fc\\u30b7\\u30e7\\u30f3\\u3067\\u3057\\u305f\\u3002\\u300dDebiopharm\\u793e\\u306fVeeva Vault eTMF\\u3092\\u5229\\u7528\\u3057\\u3001TMF\\u30d7\\u30ed\\u30bb\\u30b9\\u5168\\u4f53\\u306e\\u30aa\\u30fc\\u30d0\\u30fc\\u30b5\\u30a4\\u30c8\\u3092\\u6539\\u5584\\u3057\\u3066\\u3001\\u3088\\u308a\\u7dca\\u5bc6\\u306a\\u5354\\u696d\\u3092\\u63a8\\u9032\\u3002\",\"inLanguage\":\"ja\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/news\\\/debiopharm-international-sa-strengthens-compliance-and-clinical-trial-oversight-with-veeva-vault-etmf\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/author\\\/taeko-tajimaveeva-com\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/author\\\/taeko-tajimaveeva-com\\\/#author\"},\"datePublished\":\"2018-05-09T11:00:53+09:00\",\"dateModified\":\"2018-05-08T17:52:48+09:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/#website\",\"url\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/\",\"name\":\"Veeva Japan\",\"description\":\"The Industry Cloud for Life Sciences\",\"inLanguage\":\"ja\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.veeva.com\\\/jp\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO Pro -->\r\n\t\t<title>Debiopharm International SA\u793e\u3001Veeva Vault eTMF\u3067\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u3068\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3051\u308b\u30aa\u30fc\u30d0\u30fc\u30b5\u30a4\u30c8\u3092\u5f37\u5316 | Veeva Japan<\/title>\n\n","aioseo_head_json":{"title":"Debiopharm International SA\u793e\u3001Veeva Vault eTMF\u3067\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u3068\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3051\u308b\u30aa\u30fc\u30d0\u30fc\u30b5\u30a4\u30c8\u3092\u5f37\u5316 | Veeva Japan","description":"Debiopharm\u793e\u30b7\u30cb\u30a2\u30af\u30ea\u30cb\u30ab\u30eb\u30c8\u30e9\u30a4\u30a2\u30eb\u30a2\u30bd\u30b7\u30a8\u30fc\u30c8\u3001Sofie Lemmens\u6c0f\u30b3\u30e1\u30f3\u30c8\uff08\u629c\u7c8b\uff09\u300cVeeva Vault eTMF\u306f\u3001\u5f53\u793e\u306e\u73fe\u5728\u305d\u3057\u3066\u5c06\u6765\u306e\u30cb\u30fc\u30ba\u306b\u5408\u81f4\u3057\u305f\u3001\u5e02\u5834\u3067\u6700\u3082\u512a\u308c\u305f\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3067\u3057\u305f\u3002\u300dDebiopharm\u793e\u306fVeeva Vault eTMF\u3092\u5229\u7528\u3057\u3001TMF\u30d7\u30ed\u30bb\u30b9\u5168\u4f53\u306e\u30aa\u30fc\u30d0\u30fc\u30b5\u30a4\u30c8\u3092\u6539\u5584\u3057\u3066\u3001\u3088\u308a\u7dca\u5bc6\u306a\u5354\u696d\u3092\u63a8\u9032\u3002","canonical_url":"https:\/\/www.veeva.com\/jp\/news\/debiopharm-international-sa-strengthens-compliance-and-clinical-trial-oversight-with-veeva-vault-etmf\/","robots":"max-snippet:-1, max-image-preview:large, max-video-preview:-1","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.veeva.com\/jp\/news\/debiopharm-international-sa-strengthens-compliance-and-clinical-trial-oversight-with-veeva-vault-etmf\/#article","name":"Debiopharm International SA\u793e\u3001Veeva Vault eTMF\u3067\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u3068\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3051\u308b\u30aa\u30fc\u30d0\u30fc\u30b5\u30a4\u30c8\u3092\u5f37\u5316 | Veeva Japan","headline":"Debiopharm International SA\u793e\u3001Veeva Vault eTMF\u3067\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u3068\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3051\u308b\u30aa\u30fc\u30d0\u30fc\u30b5\u30a4\u30c8\u3092\u5f37\u5316","author":{"@id":"https:\/\/www.veeva.com\/jp\/author\/taeko-tajimaveeva-com\/#author"},"publisher":{"@id":"https:\/\/www.veeva.com\/jp\/#organization"},"datePublished":"2018-05-09T11:00:53+09:00","dateModified":"2018-05-08T17:52:48+09:00","inLanguage":"ja","mainEntityOfPage":{"@id":"https:\/\/www.veeva.com\/jp\/news\/debiopharm-international-sa-strengthens-compliance-and-clinical-trial-oversight-with-veeva-vault-etmf\/#webpage"},"isPartOf":{"@id":"https:\/\/www.veeva.com\/jp\/news\/debiopharm-international-sa-strengthens-compliance-and-clinical-trial-oversight-with-veeva-vault-etmf\/#webpage"},"articleSection":"\u30d7\u30ec\u30b9\u30ea\u30ea\u30fc\u30b9, Veeva R&amp;D"},{"@type":"BreadcrumbList","@id":"https:\/\/www.veeva.com\/jp\/news\/debiopharm-international-sa-strengthens-compliance-and-clinical-trial-oversight-with-veeva-vault-etmf\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/jp#listItem","position":1,"name":"\u30db\u30fc\u30e0","item":"https:\/\/www.veeva.com\/jp","nextItem":{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/jp\/category\/press-release\/#listItem","name":"\u30d7\u30ec\u30b9\u30ea\u30ea\u30fc\u30b9"}},{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/jp\/category\/press-release\/#listItem","position":2,"name":"\u30d7\u30ec\u30b9\u30ea\u30ea\u30fc\u30b9","item":"https:\/\/www.veeva.com\/jp\/category\/press-release\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/jp\/news\/debiopharm-international-sa-strengthens-compliance-and-clinical-trial-oversight-with-veeva-vault-etmf\/#listItem","name":"Debiopharm International SA\u793e\u3001Veeva Vault eTMF\u3067\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u3068\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3051\u308b\u30aa\u30fc\u30d0\u30fc\u30b5\u30a4\u30c8\u3092\u5f37\u5316"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/jp#listItem","name":"\u30db\u30fc\u30e0"}},{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/jp\/news\/debiopharm-international-sa-strengthens-compliance-and-clinical-trial-oversight-with-veeva-vault-etmf\/#listItem","position":3,"name":"Debiopharm International SA\u793e\u3001Veeva Vault eTMF\u3067\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u3068\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3051\u308b\u30aa\u30fc\u30d0\u30fc\u30b5\u30a4\u30c8\u3092\u5f37\u5316","previousItem":{"@type":"ListItem","@id":"https:\/\/www.veeva.com\/jp\/category\/press-release\/#listItem","name":"\u30d7\u30ec\u30b9\u30ea\u30ea\u30fc\u30b9"}}]},{"@type":"Organization","@id":"https:\/\/www.veeva.com\/jp\/#organization","name":"Veeva Systems Japan","description":"The Industry Cloud for Life Sciences","url":"https:\/\/www.veeva.com\/jp\/","sameAs":["https:\/\/www.linkedin.com\/company\/veeva-japan\/"]},{"@type":"Person","@id":"https:\/\/www.veeva.com\/jp\/author\/taeko-tajimaveeva-com\/#author","url":"https:\/\/www.veeva.com\/jp\/author\/taeko-tajimaveeva-com\/","name":"taeko.tajima@veeva.com"},{"@type":"WebPage","@id":"https:\/\/www.veeva.com\/jp\/news\/debiopharm-international-sa-strengthens-compliance-and-clinical-trial-oversight-with-veeva-vault-etmf\/#webpage","url":"https:\/\/www.veeva.com\/jp\/news\/debiopharm-international-sa-strengthens-compliance-and-clinical-trial-oversight-with-veeva-vault-etmf\/","name":"Debiopharm International SA\u793e\u3001Veeva Vault eTMF\u3067\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u3068\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3051\u308b\u30aa\u30fc\u30d0\u30fc\u30b5\u30a4\u30c8\u3092\u5f37\u5316 | Veeva Japan","description":"Debiopharm\u793e\u30b7\u30cb\u30a2\u30af\u30ea\u30cb\u30ab\u30eb\u30c8\u30e9\u30a4\u30a2\u30eb\u30a2\u30bd\u30b7\u30a8\u30fc\u30c8\u3001Sofie Lemmens\u6c0f\u30b3\u30e1\u30f3\u30c8\uff08\u629c\u7c8b\uff09\u300cVeeva Vault eTMF\u306f\u3001\u5f53\u793e\u306e\u73fe\u5728\u305d\u3057\u3066\u5c06\u6765\u306e\u30cb\u30fc\u30ba\u306b\u5408\u81f4\u3057\u305f\u3001\u5e02\u5834\u3067\u6700\u3082\u512a\u308c\u305f\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3067\u3057\u305f\u3002\u300dDebiopharm\u793e\u306fVeeva Vault eTMF\u3092\u5229\u7528\u3057\u3001TMF\u30d7\u30ed\u30bb\u30b9\u5168\u4f53\u306e\u30aa\u30fc\u30d0\u30fc\u30b5\u30a4\u30c8\u3092\u6539\u5584\u3057\u3066\u3001\u3088\u308a\u7dca\u5bc6\u306a\u5354\u696d\u3092\u63a8\u9032\u3002","inLanguage":"ja","isPartOf":{"@id":"https:\/\/www.veeva.com\/jp\/#website"},"breadcrumb":{"@id":"https:\/\/www.veeva.com\/jp\/news\/debiopharm-international-sa-strengthens-compliance-and-clinical-trial-oversight-with-veeva-vault-etmf\/#breadcrumblist"},"author":{"@id":"https:\/\/www.veeva.com\/jp\/author\/taeko-tajimaveeva-com\/#author"},"creator":{"@id":"https:\/\/www.veeva.com\/jp\/author\/taeko-tajimaveeva-com\/#author"},"datePublished":"2018-05-09T11:00:53+09:00","dateModified":"2018-05-08T17:52:48+09:00"},{"@type":"WebSite","@id":"https:\/\/www.veeva.com\/jp\/#website","url":"https:\/\/www.veeva.com\/jp\/","name":"Veeva Japan","description":"The Industry Cloud for Life Sciences","inLanguage":"ja","publisher":{"@id":"https:\/\/www.veeva.com\/jp\/#organization"}}]},"og:locale":"ja_JP","og:site_name":"Veeva Japan","og:type":"article","og:title":"Debiopharm International SA\u793e\u3001Veeva Vault eTMF\u3067\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u3068\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3051\u308b\u30aa\u30fc\u30d0\u30fc\u30b5\u30a4\u30c8\u3092\u5f37\u5316 | Veeva Japan","og:description":"Debiopharm\u793e\u30b7\u30cb\u30a2\u30af\u30ea\u30cb\u30ab\u30eb\u30c8\u30e9\u30a4\u30a2\u30eb\u30a2\u30bd\u30b7\u30a8\u30fc\u30c8\u3001Sofie Lemmens\u6c0f\u30b3\u30e1\u30f3\u30c8\uff08\u629c\u7c8b\uff09\u300cVeeva Vault eTMF\u306f\u3001\u5f53\u793e\u306e\u73fe\u5728\u305d\u3057\u3066\u5c06\u6765\u306e\u30cb\u30fc\u30ba\u306b\u5408\u81f4\u3057\u305f\u3001\u5e02\u5834\u3067\u6700\u3082\u512a\u308c\u305f\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3067\u3057\u305f\u3002\u300dDebiopharm\u793e\u306fVeeva Vault eTMF\u3092\u5229\u7528\u3057\u3001TMF\u30d7\u30ed\u30bb\u30b9\u5168\u4f53\u306e\u30aa\u30fc\u30d0\u30fc\u30b5\u30a4\u30c8\u3092\u6539\u5584\u3057\u3066\u3001\u3088\u308a\u7dca\u5bc6\u306a\u5354\u696d\u3092\u63a8\u9032\u3002","og:url":"https:\/\/www.veeva.com\/jp\/news\/debiopharm-international-sa-strengthens-compliance-and-clinical-trial-oversight-with-veeva-vault-etmf\/","article:published_time":"2018-05-09T02:00:53+00:00","article:modified_time":"2018-05-08T08:52:48+00:00"},"aioseo_meta_data":{"post_id":"41372","title":null,"description":"Debiopharm\u793e\u30b7\u30cb\u30a2\u30af\u30ea\u30cb\u30ab\u30eb\u30c8\u30e9\u30a4\u30a2\u30eb\u30a2\u30bd\u30b7\u30a8\u30fc\u30c8\u3001Sofie Lemmens\u6c0f\u30b3\u30e1\u30f3\u30c8\uff08\u629c\u7c8b\uff09\u300cVeeva Vault eTMF\u306f\u3001\u5f53\u793e\u306e\u73fe\u5728\u305d\u3057\u3066\u5c06\u6765\u306e\u30cb\u30fc\u30ba\u306b\u5408\u81f4\u3057\u305f\u3001\u5e02\u5834\u3067\u6700\u3082\u512a\u308c\u305f\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3067\u3057\u305f\u3002\u300dDebiopharm\u793e\u306fVeeva Vault eTMF\u3092\u5229\u7528\u3057\u3001TMF\u30d7\u30ed\u30bb\u30b9\u5168\u4f53\u306e\u30aa\u30fc\u30d0\u30fc\u30b5\u30a4\u30c8\u3092\u6539\u5584\u3057\u3066\u3001\u3088\u308a\u7dca\u5bc6\u306a\u5354\u696d\u3092\u63a8\u9032\u3002","keywords":null,"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[],"defaultGraph":"","defaultPostTypeGraph":""},"schema_type":null,"schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"limit_modified_date":false,"open_ai":null,"created":"2021-08-20 21:23:51","updated":"2026-08-24 03:11:10","focus_keyword":null,"additional_keywords":null,"truseo_locale":null,"ai":null,"breadcrumb_settings":null,"seo_analyzer_scan_date":"2026-08-21 16:12:46"},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/www.veeva.com\/jp\" title=\"\u30db\u30fc\u30e0\">\u30db\u30fc\u30e0<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t<a href=\"https:\/\/www.veeva.com\/jp\/category\/press-release\/\" title=\"\u30d7\u30ec\u30b9\u30ea\u30ea\u30fc\u30b9\">\u30d7\u30ec\u30b9\u30ea\u30ea\u30fc\u30b9<\/a>\n<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\tDebiopharm International SA\u793e\u3001Veeva Vault eTMF\u3067\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u3068\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3051\u308b\u30aa\u30fc\u30d0\u30fc\u30b5\u30a4\u30c8\u3092\u5f37\u5316\n<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"\u30db\u30fc\u30e0","link":"https:\/\/www.veeva.com\/jp"},{"label":"\u30d7\u30ec\u30b9\u30ea\u30ea\u30fc\u30b9","link":"https:\/\/www.veeva.com\/jp\/category\/press-release\/"},{"label":"Debiopharm International SA\u793e\u3001Veeva Vault eTMF\u3067\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u3068\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3051\u308b\u30aa\u30fc\u30d0\u30fc\u30b5\u30a4\u30c8\u3092\u5f37\u5316","link":"https:\/\/www.veeva.com\/jp\/news\/debiopharm-international-sa-strengthens-compliance-and-clinical-trial-oversight-with-veeva-vault-etmf\/"}],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/41372","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/comments?post=41372"}],"version-history":[{"count":1,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/41372\/revisions"}],"predecessor-version":[{"id":41375,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/41372\/revisions\/41375"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/media?parent=41372"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/categories?post=41372"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/tags?post=41372"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}